Jian Hua Mo
Director/Board Member bij HANGZHOU BINJIANG REAL ESTATE GROUP CO.,LTD
Vermogen: 170 M $ op 31-03-2024
Actieve functies van Jian Hua Mo
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| HANGZHOU BINJIANG REAL ESTATE GROUP CO.,LTD | Director/Board Member | 01-05-2012 | - |
| Corporate Officer/Principal | 01-01-2003 | 01-05-2012 | |
| BINJIANG SERVICE GROUP CO. LTD. | Director/Board Member | 01-12-2017 | - |
| Shanghai Binshun Investment Management Ltd | Director/Board Member | - | - |
| Hangzhou Binpu Real Estate Development Ltd. | Director/Board Member | - | - |
| Corporate Officer/Principal | - | - | |
| Hangzhou Pute Equity Investment Management Ltd. | Corporate Officer/Principal | 01-01-2017 | - |
Loopbaan van Jian Hua Mo
Eerdere bekende functies van Jian Hua Mo
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| Hangzhou Binjiang Venture Captal Investment Ltd. | Corporate Officer/Principal | 01-05-2011 | 01-11-2017 |
| Hangzhou Binjiang Real Estate Construction Co. Ltd. | Corporate Officer/Principal | 01-08-1996 | 01-12-1999 |
Ascletis Biopharmaceutical (Hangzhou) Co. Ltd.
 Ascletis Biopharmaceutical (Hangzhou) Co. Ltd. Medical SpecialtiesHealth Technology Ascletis Biopharmaceutical (Hangzhou) Co. Ltd. engages in discovering and developing new treatments for cancer and infectious diseases. The firm is currently developing ALN-VSP, a systemically delivered RNAi therapeutic comprising of two siRNAs designed to target two genes critical for the growth and development of cancer cells. It provides services to the Chinese pharmaceutical markets. The company was founded by Jinxing Qi and Jinzi J. Wu in 2011 and is headquartered in Hangzhou, China. | Director/Board Member | 08-04-2011 | - |
Opleiding van Jian Hua Mo
| Zhejiang University | Masters Business Admin |
Statistieken
Internationaal
| China | 9 |
| Kaaimaneilanden | 2 |
Operationeel
| Director/Board Member | 5 |
| Corporate Officer/Principal | 5 |
| Masters Business Admin | 1 |
Sectoraal
| Finance | 3 |
| Consumer Services | 2 |
| Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| HANGZHOU BINJIANG REAL ESTATE GROUP CO.,LTD | Finance |
| BINJIANG SERVICE GROUP CO. LTD. | Finance |
| Bedrijven in privébezit | 6 |
|---|---|
Ascletis Biopharmaceutical (Hangzhou) Co. Ltd.
Ascletis Biopharmaceutical (Hangzhou) Co. Ltd. Medical SpecialtiesHealth Technology Ascletis Biopharmaceutical (Hangzhou) Co. Ltd. engages in discovering and developing new treatments for cancer and infectious diseases. The firm is currently developing ALN-VSP, a systemically delivered RNAi therapeutic comprising of two siRNAs designed to target two genes critical for the growth and development of cancer cells. It provides services to the Chinese pharmaceutical markets. The company was founded by Jinxing Qi and Jinzi J. Wu in 2011 and is headquartered in Hangzhou, China. | Health Technology |
| Shanghai Binshun Investment Management Ltd | |
| Hangzhou Binpu Real Estate Development Ltd. | |
| Hangzhou Pute Equity Investment Management Ltd. | |
| Hangzhou Binjiang Venture Captal Investment Ltd. | |
| Hangzhou Binjiang Real Estate Construction Co. Ltd. |
- Beurs
- Insiders
- Jian Hua Mo
- Ervaring
